Antitumor effect induced by the expression of granulocyte macrophage-colony stimulating factor gene in murine colon carcinoma cells

Cancer Letters

Volumn 101, Issue 2, 1996, Pages 257-261

  Gunji, Yoshio ^a   Tagawa, Masatoshi ^a   Matsubara, Hisahiro ^a   Takenaga, Keizo ^b   Shimada, Hideaki ^a   Kondo, Fukuo ^a   Suzuki, Takao ^a   Nakajima, Kazuaki ^a   Sugaya, Makoto ^a   Asano, Takehide ^a   Ochiai, Takenori ^a   Isono, Kaichi ^a   Horitsu, Keisuke ^c   Kageyama, Hajime ^b   Nakamura, Yohko ^b   Sakiyama, Shigeru ^b  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA CANCER CENTER   (Japan)

^c TOKYO KASEI UNIVERSITY   (Japan)

Author keywords

Colon tumor; Cytokine; Gene therapy

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; INTERLEUKIN 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOGENICITY; CARCINOMA CELL; COLON CARCINOMA; GENE EXPRESSION; GENE THERAPY; HISTOLOGY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; TUMOR NECROSIS;

ANIMALIA; MURINAE;

EID: 0029968802     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04141-9     Document Type: Article

References (27)

1. Sobol, R.E. and Scanlon, K.J. (1995) Cancer gene therapy clinical trials. Cancer Gene Ther., 2, 5-6.
2. Carbone, D.P. and Minna, J.D. (1994) In vivo gene therapy of human lung cancer using wild-type p53 delivered by retrovirus. J. Natl. Cancer Inst., 86, 1437-1438.
3. Moolten, F.L. (1994) Drug sensitivity ('suicide') genes for selective cancer chemotherapy. Cancer Gene Ther., 1, 279-287.
4. Tepper, R.I. and Mulé, J.J. (1994) Experimental and clinical studies of cytokine gene-modified tumor cells. Hum. Gene Ther., 5, 153-164.
5. Tepper, R.I., Pattengale, P.K. and Leder, P. (1989) Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell, 57, 503-512.
6. Golumbek, P.T., Lazenby, A.J., Levitsky, H.I., Jaffee, L.M., Karasuyama, H., Baker, M. and Pardoll, D.M. (1991) Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science, 254, 713-716.
7. Tepper, R.I., Coffman, R.L. and Leder, P. (1992) An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science, 257, 548-551.
8. Ohira, T., Ohe, Y., Heike, Y., Podack, E.R., Olsen, K.J., Nishio, K., Nishio, M., Miyahara, Y., Funayama, Y., Ogasawara, H., Arioka, H., Kunikane, H., Fukuda, M., Kato, H. and Saijo, N. (1994) In vitro and in vivo growth of B16F10 melanoma cells transfected with interleukin-4 cDNA and gene therapy with the transfectant. J. Cancer Res. Clin. Oncol., 120, 631-635.
9. Wel, M.X., Tamiya, T., Hurford, JR.R.K., Boviatsis, E.J., Tepper, R.I. and Chiocca, E.A. (1995) Enhancement of interleukin-4-mediated tumor regression in athymic mice by in situ retroviral gene transfer. Hum. Gene Ther., 6, 437-443.
10. Mullen, C.A., Coale, M.M., Levy, A.T., Stetler-Stevenson, W.G., Liotta, L.A., Brandt, S. and Blaese, R.M. (1992) Fibrosarcoma cells transduced with the IL-6 gene exhibit reduced tumorigenicity, increased immunogenicity, and decreased metastatic potential. Cancer Res., 52, 6020-6024.
11. Porgador, A., Tzehoval, E., Katz, A., Vadai, E., Revel, M., Feldman, M. and Eisenbach, L. (1992) Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells. Cancer Res., 52, 3679-3686.
12. Sun, W.H., Kreisle, R.A., Phillips, A.W. and Ershler, W.B. (1992) In vivo and in vitro characteristics of interleukin 6-transfected B16 melanoma cells. Cancer Res., 52, 5412-5415.
13. Sun, W.H., Burkholder, J.K., Sun, J., Culp, J., Turner, J., Lu, X.G., Pugh, T.D., Ershler, W.B. and Yang, N.-S. (1995) In vivo cytokine gene transfer by gene gun reduces tumor growth in mice. Proc. Natl. Acad. Sci. USA, 92, 2889-2893.
14. Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D. and Mulligan, R.C. (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA, 90, 3539-3543.
15. Sanda, M.G., Ayyagari, S.R., Jaffee, E.M., Epstein, J.I., Clift, S.L., Cohen, L.K., Dranoff, G., Pardoll, D.M., Mulligan, R.C. and Simons, J.W. (1994) Demonstration of a rational strategy for human prostate cancer gene therapy. J. Urol., 151, 622-628.
16. Fearon, E.R., Pardoll, D.M., Itaya, T., Golumbek, P., Levitsky, H.I., Simons, J.W., Karasuyama, H., Vogelstein, B. and Frost, P. (1990) Interleukin-2 production by tumor cells by-passes T helper function in the generation of an antitumor response. Cell, 60, 397-403.
17. Gastl, G., Finstad, C.L., Guarini, A., Bosl, G., Gilboa, E., Bander, N.H. and Gansbacher, B. (1992) Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells. Cancer Res., 52, 6229-6236.
18. Cignetti, A., Guarini, A., Carbone, A., Forni, M., Cronin, K., Forni, G., Gansbacher, B. and Foa, R. (1994) Transduction of the IL2 gene into human acute leukemia cells: induction of tumor rejection without modifying cell proliferation and IL2 receptor expression. J. Natl. Cancer Inst., 86, 785-791.
19. Corbett, T.H., Grinswold, Jr., D.P., Roberts, B.J., Peckham, J.C. and Schabel, Jr., F.M. (1975) Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res., 35, 2434-2439.
20. Brattain, M.G., Strobel-Stevens, J., Fine, D., Webb, M. and Sarrif, A.M. (1980) Establishment of mouse colonie carcinoma cell lines with different metastatic properties. Cancer Res., 40, 2142-2146.
21. Miller, A.D. and Rosman, G.J. (1989) Improved retroviral vectors for gene transfer and expression. BioTechniques, 7, 980-990.
22. Yasukawa, K., Hirano, T., Watanabe, Y., Muratani, K., Matsuda, T., Nakai, S. and Kisimoto, T. (1987) Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene. EMBO J., 6, 2939-2945.
23. Lee, F., Yokota, T., Otuka, T., Meyerson, P., Villaret, D., Coffman, R., Mosmann, T., Rennick, D., Roehm ,N., Smith, C., Zlotnik, A. and Arai, K.-I. (1986) Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell-and mast-cell-stimulating activities. Proc. Natl. Acad. Sci. USA, 83, 2061-2065.
24. Miyatake, S., Otsuka, T., Yokota, T., Lee, F. and Arai, K-I. (1985) Structure of the chromosomal gene for granulocyte-macrophage colony stimulating factor: comparison of the mouse and human genes. EMBO J., 4, 2561-2568.
25. Steinman, R.M. (1991) The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol., 9, 271-296.
26. Restifo, N.P., Esquivel, F., Kawakami, Y., Yewdell, J.W., Mulé, J.J., Rosenberg, S.A. and Bennink, JR. (1993) Identification of human cancers deficient in antigen processing. J. Exp. Med., 177, 265-272.
27. Saito, S., Bannerji, R., Gansbacher, B., Rosenthal, F.M., Romanenko, P., Heston, W.D.W., Fair, W.R. and Gilboa, E. (1994) Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines. Cancer Res., 54, 3516-3520.